Concepedia

Publication | Closed Access

A Phase I and pharmacokinetic study of high dose tamoxifen and weekly cisplatin in patients with metastatic melanoma

DOI

20

Citations

17

References

1997

Year

Edward F. McClay, Mary-Eileen T. McClay, Jeffrey A. Jones, P J Winski, Randolf D. Christen, Stephen B. Howell, Philip D. Hall
Cancer

Abstract

A TAM dose of 240 mg/day is the recommended Phase II dose. Based on the 38.5% overall response rate at this dose, the authors have initiated a Phase II study.

References

YearCitations

Page 1